| Mammary tumor development in dogs is associated with BRCA1 and BRCA2 P Rivera, M Melin, T Biagi, T Fall, J Häggström, K Lindblad-Toh, ... Cancer Research 69 (22), 8770-8774, 2009 | 204 | 2009 |
| Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B EK Karlsson, S Sigurdsson, E Ivansson, R Thomas, I Elvers, J Wright, ... Genome biology 14, 1-16, 2013 | 174 | 2013 |
| Molecular biological aspects on canine and human mammary tumors P Rivera, H Von Euler Veterinary pathology 48 (1), 132-146, 2011 | 145 | 2011 |
| Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma H von Euler, A Sadeghi, B Carlsson, P Rivera, A Loskog, T Segall, ... Journal of Immunotherapy 31 (4), 377-384, 2008 | 61 | 2008 |
| Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity-evaluation of a new, fully automated non-radiometric assay HP Von Euler, P Rivera, AC Aronsson, C Bengtsson, LO Hansson, ... International journal of oncology 34 (2), 505-510, 2009 | 45 | 2009 |
| Genome-wide analysis identifies germ-line risk factors associated with canine mammary tumours M Melin, P Rivera, M Arendt, I Elvers, E Muren, U Gustafson, M Starkey, ... PLoS Genetics 12 (5), e1006029, 2016 | 36 | 2016 |
| A dose‐finding study with a novel water‐soluble formulation of paclitaxel for the treatment of malignant high‐grade solid tumours in dogs H Von Euler, P Rivera, H Nyman, J Häggström, O Borgå Veterinary and comparative oncology 11 (4), 243-255, 2013 | 35 | 2013 |
| The ESR1 gene is associated with risk for canine mammary tumours KS Borge, M Melin, P Rivera, SI Thoresen, MT Webster, H Von Euler, ... BMC veterinary research 9, 1-9, 2013 | 25 | 2013 |
| Clinical efficacy and safety of a water‐soluble micellar paclitaxel (Paccal Vet) in canine mastocytomas P Rivera, N Åkerlund‐Denneberg, K Bergvall, M Kessler, A Rowe, ... Journal of Small Animal Practice 54 (1), 20-27, 2013 | 24 | 2013 |
| Biochemical markers and genetic risk factors in canine tumors P Rivera Department of Clinical Sciences, Swedish University of Agricultural Sciences, 2010 | 11 | 2010 |
| PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia ML Arendt, S Sakthikumar, M Melin, I Elvers, P Rivera, M Larsen, ... Scientific Reports 13 (1), 632, 2023 | 9 | 2023 |
| Mammatumoren beim Hund–Teil 1: Ein Überblick über Risikofaktoren und die histologische Klassifikation D Krastel kleintier konkret 20 (04), 10-16, 2017 | | 2017 |
| Identification of a rare dog leucocyte antigen class II haplotype as a protective factor against canine mammary tumours P Rivera, M Melin, M Wilbe, J Häggströ, K Lindblad-Toh, G Andersson, ... Veterinary and Comparative Oncology 9 (2), 2011 | | 2011 |
| BRCA1, BRCA2 and DLA class II are associated with canine mammary tumour development P Rivera, M Melin, M Wilbe, T Biagi, T Fall, J Haggstrom, K Lindblad-Toh, ... Veterinary and Comparative Oncology 9 (1), 2011 | | 2011 |
| Paediatric Oncology N Binz, T Shalaby, P Rivera, K Shin-ya, MA Grotzer, EA Earle, H Davies, ... | | |
